NCT06786585View on ClinicalTrials.gov

Extended Clinical Follow up and Biospecimen Collection for Patients Enrolled in TAILORx and RxPONDER: A Companion Protocol

Not yet recruitingOBSERVATIONAL

Enrollment

600

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2028

Conditions

Breast Cancer

All Listed Sponsors

collaborator

United States Department of Defense

FED

lead

Eastern Cooperative Oncology Group

NETWORK